Devin Whittemore Smith is General Counsel of IO Biotech, Inc.. Currently has a direct ownership of 4,938 shares of IOBT, which is worth approximately $3,802. The most recent transaction as insider was on Aug 09, 2023, when has been sold 4,938 shares (Common Stock) at a price of $1.9 per share, resulting in proceeds of $9,382. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.94K
0% 3M change
0% 12M change
Total Value Held $3,802

Devin Whittemore Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2023
BUY
Grant, award, or other acquisition
$9,382 $1.9 p/Share
4,938 Added 50.0%
4,938 Common Stock

Also insider at

NERV
Minerva Neurosciences, Inc. Healthcare
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
DWS

Devin Whittemore Smith

General Counsel
Waltham, MA

Track Institutional and Insider Activities on IOBT

Follow IO Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOBT shares.

Notify only if

Insider Trading

Get notified when an Io Biotech, Inc. insider buys or sells IOBT shares.

Notify only if

News

Receive news related to IO Biotech, Inc.

Track Activities on IOBT